nach oben

Journal of Diabetes & Metabolic Disorders

Erschienen in:

22.07.2022 | Review article

Efficacy of the holistic, psychonutritional approach of Centro DAI e Obesità di Città della Pieve in the management of type 2 diabetes among patients with obesity and dysfunctional eating

verfasst von: Luisa Barana, Georgia Colleluori, Maria Teresa Sulpizi, Kathleen Ortenzi, Luca Farano, Carmine Giuseppe Fanelli, Riccardo Calafiore, Laura Dalla Ragione, Simone Pampanelli

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Dysfunctional eating is strongly associated with obesity and worsens type 2 diabetes (T2DM) outcomes. The aim of this study was to investigate the effectiveness of the psycho-nutritional treatment (PNT) of “Centro DAI e Obesità” of Città della Pieve on weight loss and glucose management in dysfunctional eaters with obesity and T2DM.

Methods

PNT includes psychotherapeutical, nutritional, physical and social activities. Subjects with obesity, T2DM and dysfunctional eating habits who completed the 8 weeks residential program between 2010 and 2019 were compared with obese, T2DM, dysfunctional eaters who underwent to a conventional, hospital-based, nutritional treatment (CT). Anthropometric variables, glucolipid panel, and body composition were assessed at baseline and at the end of the program. Weight and HbA1c were also measured after one year from the completion.

Results

Sixty-nine patients completed the PNT and reduced weight (−7 ± 3.2%; p < 0.001), BMI (−7 ± 3.1%; p < 0.001), and triglycerides, AST, GGT and ALT (p ≤ 0.008); glycemic control improved (HbA1c: −1.1 ± 1.5%, mean fasting glucose: −41 ± 46 mg/dl, p < 0.001). Eleven% of subjects requiring diabetes medications at baseline discontinued the therapy. In the insulin treated group (49%), mean daily units were halved (−32.6 ± 26.0, p < 0.001). At one year, weight loss (−6 ± 7.4%, p < 0.001) and HbA1c reduction (−0.52 ± 1.4%, p = 0.029) persisted. Fifty-five patients completed the CT: HbA1c reduced (p = 0.02), but weight (−0.6 ± 3.7%), BMI (−0.7 ± 3.8%), and insulin units’ reduction (−2.5 ± 11.7, p = 0.20) were lower compared to the PNT.

Conclusion

PNT is effective in improving T2DM management in patients with obesity and dysfunctional eating.

Sims EA, Danforth E Jr, Horton ES, Bray GA, Glennon JA, Salans LB. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res. 1973;29:457–96. https://doi.org/10.1016/b978-0-12-571129-6.50016-6.CrossRefPubMed

Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840–6. https://doi.org/10.1038/nature05482.CrossRefPubMed

McCuen-Wurst C, Ruggieri M, Allison KC. Disordered eating and obesity: associations between binge-eating disorder, night-eating syndrome, and weight-related comorbidities. Ann N Y Acad Sci 2018;1411(1):96–105.https://doi.org/10.1111/nyas.13467.

Thornton LM, Watson HJ, Jangmo A, et al. Binge-eating disorder in the Swedish national registers: somatic comorbidity. Int J Eat Disord. 2017;50(1):58–65. https://doi.org/10.1002/eat.22624.CrossRefPubMed

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.CrossRef

Ruocco G, Andrioli Stagno R, Ballardini D, Cotugno A, Dalla Ragione L, Dalle Grave R, et al. Linee di Indirizzo Nazionale per la riabilitazione Nutrizionale dei Disturbi dell’Alimentazione. Quaderni del Ministero della Salute. 2017;29:59–64.

Badimon L, Bugiardini R, Cenko E, et al. Position paper of the European Society of Cardiology-working group of coronary pathophysiology and microcirculation: obesity and heart disease. Eur Heart J. 2017;38(25):1951–8. https://doi.org/10.1093/eurheartj/ehx181.CrossRefPubMed

Colleluori G, Napoli N, Phadnis U, Armamento-Villareal R, Villareal DT. Effect of weight loss, exercise, or both on Undercarboxylated osteocalcin and insulin secretion in frail, obese older adults. Oxidative Med Cell Longev. 2017;2017:4807046. https://doi.org/10.1155/2017/4807046.CrossRef

Bouchonville M, Armamento-Villareal R, Shah K, et al. Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial. Int J Obes. 2014;38(3):423–31. https://doi.org/10.1038/ijo.2013.122.CrossRef

10.

Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the community preventive services task force. Ann Intern Med. 2015;163(6):437–51. https://doi.org/10.7326/M15-0452.CrossRefPubMedPubMedCentral

11.

Mannucci E, Tesi F, Ricca V, Pierazzuoli E, Barciulli E, Moretti S, et al. Eating behavior in obese patients with and without type 2 diabetes mellitus. Int JObes Relat Metab Disord. 2002;26:848–53.CrossRef

12.

Dalla Ragione L. Lavorare insieme: l’equipe multidisciplinare. In: Prigionieri del cibo. Il Pensiero Scientifico Editore, pp. 99–109, 2016.

13.

Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–253.

14.

American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14-S31. https://doi.org/10.2337/dc20-S002.

15.

Pampanelli S, Bartolini L. La riabilitazione Nutrizionale. In: Prigionieri del cibo. Il Pensiero Scientifico Editore, pp. 113–119, 2016.

16.

Koch SC, Riege RFF, Tisborn K, Biondo J, Martin L, Beelmann A. Effects of Dance Movement Therapy and Dance on Health-Related Psychological Outcomes. A Meta-Analysis Update. Front Psychol. 2019;10:1806. Published 2019 Aug 20. https://doi.org/10.3389/fpsyg.2019.01806.

17.

Becker BE. Aquatic therapy: scientific foundations and clinical rehabilitation applications. PM R. 2009 Sep;1(9):859–72. https://doi.org/10.1016/j.pmrj.2009.05.017.CrossRefPubMed

18.

Bates A. Of patients & horses. Equine-facilitated psychotherapy. J Psychosoc Nurs Ment Health Serv. 2002;40(5):16–9.CrossRefPubMed

19.

Di Loreto C, Fanelli C, Lucidi P, et al. Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. Diabetes Care. 2005;28(6):1295–302. https://doi.org/10.2337/diacare.28.6.1295.CrossRefPubMed

20.

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.CrossRefPubMed

21.

American Diabetes Association. 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2020 [published correction appears in Diabetes Care. 2020 Aug;43(8):1980]. Diabetes Care. 2020;43(Suppl 1):S89-S97. https://doi.org/10.2337/dc20-S008.

22.

Evert AB, Dennison M, Gardner CD, et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. 2019;42(5):731–54. https://doi.org/10.2337/dci19-0014.CrossRefPubMedPubMedCentral

23.

Chevinsky JD, Wadden TA, Chao AM. Binge eating disorder in patients with type 2 diabetes: diagnostic and management challenges. Diabetes Metab Syndr Obes 2020;13:1117–1131. Published 2020 Apr 14. https://doi.org/10.2147/DMSO.S213379.

24.

Brown A, Guess N, Dornhorst A, Taheri S, Frost G. Insulin-associated weight gain in obese type 2 diabetes mellitus patients: what can be done? Diabetes Obes Metab. 2017;19(12):1655–68. https://doi.org/10.1111/dom.13009.CrossRefPubMed

25.

American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S61-S70. https://doi.org/10.2337/dc19-S006.

26.

Parry S, Woods R, Hodson L, Hulston C. A single day of excessive dietary fat intake reduces whole-body insulin sensitivity: the metabolic consequence of binge eating. Nutrients. 2017;9(8):818. https://doi.org/10.3390/nu9080818.CrossRefPubMedCentral

27.

Abbott S, Dindol N, Tahrani AA, Piya MK. Binge eating disorder and night eating syndrome in adults with type 2 diabetes: a systematic review. J Eat Disord; 6:36, 2018.

28.

Petroni ML, Barbanti FA, Bonadonna R, et al. Dysfunctional eating in type 2 diabetes mellitus: a multicenter Italian study of socio-demographic and clinical associations. Nutr Metab Cardiovasc Dis. 2019;29(9):983–90. https://doi.org/10.1016/j.numecd.2019.06.006.CrossRefPubMed

29.

Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes prevention program research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.CrossRefPubMed

30.

The Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet. 2009;374(9702):1677–86. https://doi.org/10.1016/S0140-6736(09)61457-4.CrossRef

31.

Hemmingsen B, Gimenez-Perez G, Mauricio D, Roqué I Figuls M, Metzendorf MI, Richter B. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev. 2017;12(12):CD003054. Published 2017 Dec 4. https://doi.org/10.1002/14651858.CD003054.pub4.

32.

Sbroma Tomaro E, Pippi R, Reginato E, et al. Intensive lifestyle intervention is particularly advantageous in poorly controlled type 2 diabetes. Nutr Metab Cardiovasc Dis. 2017;27(8):688–94. https://doi.org/10.1016/j.numecd.2017.06.009.CrossRefPubMed

33.

Liu G, PhDa YL, Hu Y. Influence of lifestyle on incident cardiovascular disease and mortality in patients with diabetes mellitus. J Am Coll Cardiol. 2018;71(25):2867–76.CrossRefPubMedPubMedCentral

34.

Taheri S, Zaghloul H, Chagoury O, et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2020;8(6):477–89. https://doi.org/10.1016/S2213-8587(20)30117-0.CrossRefPubMed

35.

Lean ME, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541–51. https://doi.org/10.1016/S0140-6736(17)33102-1.CrossRefPubMed

36.

Lean MEJ, Leslie WS, Barnes AC, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster randomised trial. Lancet Diabetes Endocrinol. 2019;7:344–55.CrossRefPubMed

37.

Gregg EW, Chen H, Wagenknecht LE, Look AHEAD Research Group. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012;308(23):2489–96. https://doi.org/10.1001/jama.2012.67929.CrossRefPubMedPubMedCentral

38.

Papelbaum M, de Oliveira Moreira R, Coutinho WF, et al. Does binge-eating matter for glycemic control in type 2 diabetes patients?. J Eat Disord. 2019;7:30. Published 2019 Sep 6. https://doi.org/10.1186/s40337-019-0260-4.

39.

Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82–97. https://doi.org/10.1016/j.metabol.2018.11.014.CrossRefPubMed

40.

Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599–612. https://doi.org/10.1038/s41575-021-00448-y.CrossRefPubMed

41.

Paris T, George ES, Roberts SK, Tierney AC. The effects of diet and lifestyle interventions on insulin resistance in patients with nonalcoholic fatty liver disease: a systematic review. Eur J Gastroenterol Hepatol. 2017;29(8):867–78. https://doi.org/10.1097/MEG.0000000000000890.CrossRefPubMed

42.

European Association for the Study of the liver (EASL); European Association for the Study of diabetes (EASD); European Association for the Study of obesity (EASO). EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. Diabetologia. 2016;59(6):1121–40. https://doi.org/10.1007/s00125-016-3902-y.

43.

Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L. Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis. World J Gastroenterol. 2018;24(30):3361–73. https://doi.org/10.3748/wjg.v24.i30.3361.CrossRefPubMedPubMedCentral

44.

Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367–e15. https://doi.org/10.1053/j.gastro.2015.04.005.CrossRefPubMed

45.

King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999;48(5):643–8. https://doi.org/10.1046/j.1365-2125.1999.00092.x.CrossRefPubMedPubMedCentral

46.

The diabetes control and complications trial research group the effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.

47.

Unick JL, Beavers D, Bond DS, Clark JM, Jakicic JM, Kitabchi AE, Knowler WC, Wadden TA, Wagenknecht LE, Wing RR. Look AHEAD research group. The long-term effectiveness of a lifestyle intervention in severely obese individuals. Am J Med. 2013;126(3):236–42.CrossRefPubMedPubMedCentral

48.

Gorin AA, Niemeier HM, Hogan P, et al. Binge eating and weight loss outcomes in overweight and obese individuals with type 2 diabetes: results from the look AHEAD trial. Arch Gen Psychiatry. 2008;65(12):1447–55. https://doi.org/10.1001/archpsyc.65.12.1447.CrossRefPubMedPubMedCentral

49.

Chao AM, Wadden TA, Gorin AA, et al. Binge eating and weight loss outcomes in individuals with type 2 diabetes: 4-year results from the look AHEAD study. Obesity (Silver Spring). 2017;25(11):1830–7. https://doi.org/10.1002/oby.21975.CrossRefPubMedCentral

50.

Linardon J, Wade TD, De La Piedad GX, Brennan L. The efficacy of cognitive-behavioral therapy for eating disorders: a systematic review and meta-analysis. J Consult Clin Psychol. 2017;85(11):1080–94. https://doi.org/10.1037/ccp0000245.CrossRefPubMed

51.

Dalle Grave R, Sartirana M, Calugi S. Personalized cognitive-behavioural therapy for obesity (CBT-OB): theory, strateges and procedures. Biopsychosoc Med. 2020;14(1):5. https://doi.org/10.1186/s13030-020-00177-9.CrossRefPubMedPubMedCentral

52.

Uchendu C, Blake H. Effectiveness of cognitive–behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Diabet Med. 2017;34:328–39. https://doi.org/10.1111/dme.13195.CrossRefPubMed

53.

Aschner P. Insulin therapy in type 2 diabetes. Am J Ther. 2020;27(1):e79–90. https://doi.org/10.1097/MJT.0000000000001088.CrossRefPubMed

54.

Colleluori G, Goria I, Zillanti C, Marucci S, Dalla RL. Eating disorders during COVID-19 pandemic: the experience of Italian healthcare providers. Eat Weight Disord. 2021;9:1–7. https://doi.org/10.1007/s40519-021-01116-5.CrossRef

Titel: Efficacy of the holistic, psychonutritional approach of Centro DAI e Obesità di Città della Pieve in the management of type 2 diabetes among patients with obesity and dysfunctional eating
verfasst von: Luisa Barana
Georgia Colleluori
Maria Teresa Sulpizi
Kathleen Ortenzi
Luca Farano
Carmine Giuseppe Fanelli
Riccardo Calafiore
Laura Dalla Ragione
Simone Pampanelli
Publikationsdatum: 22.07.2022
Verlag: Springer International Publishing
Erschienen in: Journal of Diabetes & Metabolic Disorders / Ausgabe 2/2022
Elektronische ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-022-01085-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Bildnachweise

Die Leitlinien für Ärztinnen und Ärzte, Digitale Mammographien links in kraniokaudaler Projektion./© Weigel, S. et al. / all rights reserved Springer Medizin Verlag GmbH, Operation bei Blasenkrebs/© anistidesign / Fotolia, Medizinische Fachangestellte sitzt erschöpft auf der Treppe/© Courtney Haas / peopleimages.com /stock.adobe.com (Symbolbild mit Fotomodell), Mann wird von Ärztin untersucht/© Tashi-Delek, Getty Images, iStock (Symbolbild mit Fotomodellen)

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2022

Stem cell therapy for type 1 diabetes: a scientometric assessment of global research during the twenty-first century

Evaluation of the predictive value of different dietary antioxidant capacity assessment methods on healthy and unhealthy phenotype in overweight and obese women

The views and experiences of people with type 2 diabetes being cared for by their community pharmacist: a cross-sectional patient survey

Medical management of pancreatic neuroendocrine tumors in patients with MEN 1: case report

Circulating salivary and serum miRNA-182, 320a, 375 and 503 expression levels in type 2 diabetes